Kite Pharma, Inc. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Kite Pharma, Inc. reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $431.66 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-08-08
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-06-30 was $14.48M, a 1611.11% increase year-over-year.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $417.19M, a 45493.99% increase year-over-year.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was -$647.00K, a 131.12% decline year-over-year.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was $846.00K, a 37.34% increase year-over-year.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $307.66M, a 15.51% decline from fiscal 2014.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $364.15M, a 1758.20% increase from fiscal 2013.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $19.60M, a 7585.10% increase from fiscal 2012.
- Kite Pharma, Inc. net cash provided by (used in) financing activities, continuing operations for fiscal 2012 was $255.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|
| 2017-06-30 | $14.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $431.66M 10-Q · filed 2017-08-08 | ||||
| 2017-03-31 | $417.19M 10-Q · filed 2017-05-08 | |||||
| 2016-09-30 | -$647.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $199.00K derived: sum of 2 quarters · filed 2017-08-08 | $1.11M 10-Q · filed 2016-11-09 | $279.36M derived: sum of 4 quarters · filed 2017-08-08 | ||
| 2016-06-30 | $846.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.76M 10-Q · filed 2017-08-08 | $920.00K 10-Q · filed 2016-08-08 | $280.00M derived: sum of 3 quarters · filed 2017-08-08 | $282.08M derived: sum of 4 quarters · filed 2017-08-08 | |
| 2016-03-31 | $915.00K 10-Q · filed 2017-05-08 | $435.00K 10-Q · filed 2016-05-09 | $279.16M derived: sum of 2 quarters · filed 2017-05-08 | $281.24M derived: sum of 3 quarters · filed 2017-05-08 | $281.85M derived: sum of 4 quarters · filed 2017-05-08 | |
| 2015-12-31 | $278.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $280.32M derived: sum of 2 quarters · filed 2016-11-09 | $280.94M derived: sum of 3 quarters · filed 2016-11-09 | $307.66M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.69M derived: sum of 2 quarters · filed 2016-11-09 | $29.42M 10-Q · filed 2016-11-09 | $206.51M derived: sum of 4 quarters · filed 2016-11-09 | ||
| 2015-06-30 | $616.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $27.34M 10-Q · filed 2016-08-08 | $204.43M derived: sum of 3 quarters · filed 2016-08-08 | $202.89M derived: sum of 4 quarters · filed 2016-08-08 | ||
| 2015-03-31 | $26.73M 10-Q · filed 2016-05-09 | $203.82M derived: sum of 2 quarters · filed 2016-05-09 | $202.28M derived: sum of 3 quarters · filed 2016-05-09 | $390.96M derived: sum of 4 quarters · filed 2016-05-09 | ||
| 2014-12-31 | $177.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $175.55M derived: sum of 2 quarters · filed 2016-02-29 | $364.23M derived: sum of 3 quarters · filed 2016-02-29 | $364.15M 10-K · filed 2016-02-29 | ||
| 2014-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $187.14M derived: sum of 2 quarters · filed 2015-11-12 | $187.06M 10-Q · filed 2015-11-12 | $187.06M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $188.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $188.60M 10-Q · filed 2015-08-10 | $188.60M derived: sum of 3 quarters · filed 2016-02-29 | $188.60M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | -$81.00K 10-Q · filed 2015-05-15 | -$81.00K derived: sum of 2 quarters · filed 2016-02-29 | -$81.00K derived: sum of 3 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $19.60M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $19.60M 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $19.60M 10-Q · filed 2014-08-14 | |||||
| 2012-12-31 | $255.00K 10-K · filed 2015-03-26 |